Abstract:
본 발명은 육두구 유래의 AMP-활성 단백질키나제 효소(AMP-activated protein kinase; AMPK)를 활성화시키는 2,5-비스-아릴-3,4-디메틸테트라하이드로퓨란 리그난계 화합물 및 이를 유효성분으로 포함하는 비만과 같은 대사증후군(metabolic syndrome)의 예방과 치료용 조성물에 관한 것으로, 더욱 상세하게는 육두구를 30%이하 에탄올 수용액으로 추출한 후 크로마토그래피를 이용하여 순수 분리 정제하여 얻은 하기 화학식 1로 표시되는 2,5-비스-아릴-3,4-디메틸테트라하이드로퓨란 리그난계 화합물 중 어느 하나를 포함하는 AMPK 활성화 화합물과 이를 유효성분으로 함유하는 비만, 당뇨, 고지혈증, 심혈관계 질환 등과 같은 AMPK 효소의 활성화에 따른 대사증후군 관련 질환의 예방 및 치료용 조성물에 관한 것이다. 육두구, AMPK, 2,5-비스-아릴-3,4-디메틸테트라하이드로퓨란 리그난, 비만, 대사증후군
Abstract:
PURPOSE: A Myristica fragrans-derived 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignan is provided to activates AMP-activated protein kinase(AMPK) and to prevent and treat metabolic syndrome-associated diseases. CONSTITUTION: A Myristica fragrans extract is obtained by isolating Myristica fragrans with 10-30% of ethanol solution and contains lignin compounds of nectandrin B, nectandrin A, fragransin C1, verrucosin, saucernetin or tetrahydrofuroguaiacin. A functional food for treating obesity or metabolic syndrome contains Myristica fragrans extract.
Abstract:
PURPOSE: A compound which activates Erythrina abyssinica-derived AMPK is provided to prevent and treat diabetes, obesity, or metabolic syndrome with less cytotoxicity. CONSTITUTION: An Erythrina abyssinica extract for preventing or treating obesity or metabolic syndrome contains erythribyssin F, erythribyssin N, erythribyssin O, sigmoidin K, isosojagol, eryvarin, or erypoegin F. A health food or pharmaceutical composition for preventing or treating obesity or metabolic syndrome contains the Erythrina abyssinica extract as an active ingredient. The pharmaceutical composition also contains pharmaceutically acceptable carrier or excipient.
Abstract:
PURPOSE: A compound which activates Erythrina abyssinica-derived AMPK is provided to prevent and treat diabetes, obesity, or metabolic syndrome with less cytotoxicity. CONSTITUTION: An Erythrina abyssinica extract for preventing or treating obesity or metabolic syndrome contains erythribyssin F, erythribyssin N, erythribyssin O, sigmoidin K, isosojagol, eryvarin, or erypoegin F. A health food or pharmaceutical composition for preventing or treating obesity or metabolic syndrome contains the Erythrina abyssinica extract as an active ingredient. The pharmaceutical composition also contains pharmaceutically acceptable carrier or excipient.